Charity Accounts Intelreading the accounts so you don’t have to

THE CHRONIC DISEASE RESEARCH FOUNDATION

Registered charity 1186102 · accounts filings on the Charity Commission register · also known as CDRF

Latest income
£214k
Latest spending
£947k
Registered
2019
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity reported a deficit of £732,638 for the year ended 5 April 2025, resulting in closing net assets of £5,112,615. The trustees' report confirms that unrestricted funds of £543,110 remain well above the stated policy minimum of approximately six months' projected management and administrative expenditure. The independent auditors confirmed that the use of the going concern basis of accounting is appropriate with no material uncertainties identified.

What the accounts disclose

Reserves policy: approximately six months’ projected management and administrative expenditure (held: £543k)
“The trustees’ policy regarding free reserves is to set a minimum for such reserves equal to approximately six months’ projected management and administrative expenditure.” — page 5
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Collyer Bristow LLP, a firm where Trustee Mr M D B Simon is a partner, was charged £9,000 for administration and other legal services.
“During the year, £9,000 (2024: £2,880) was charged by Collyer Bristow for administration and other legal services. Mr M D B Simon, Trustee, is a partner of Collyer Bristow.” — page 26
“Expenditure in the year includes £234,225 (2024: £189,669) to projects of which Professor Tim Spector (Medical Director) is the lead researcher. A further £158,493 (2024: £1,035,248) has been approved for payment to projects led by Professor Spector.” — page 26
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: Expenditure of £234,225 was incurred on projects led by Medical Director Professor Tim Spector, with a further £158,493 approved for payment to his projects.
“During the year, £9,000 (2024: £2,880) was charged by Collyer Bristow for administration and other legal services. Mr M D B Simon, Trustee, is a partner of Collyer Bristow.” — page 26
“Expenditure in the year includes £234,225 (2024: £189,669) to projects of which Professor Tim Spector (Medical Director) is the lead researcher. A further £158,493 (2024: £1,035,248) has been approved for payment to projects led by Professor Spector.” — page 26
Per its FY2025 accounts as filed with the Charity Commission.
Related-party transaction: The Foundation holds an option to buy shares in Zoe Limited, founded by Medical Director Professor Tim Spector, valued at no more than £4,900.
“During the year, £9,000 (2024: £2,880) was charged by Collyer Bristow for administration and other legal services. Mr M D B Simon, Trustee, is a partner of Collyer Bristow.” — page 26
“Expenditure in the year includes £234,225 (2024: £189,669) to projects of which Professor Tim Spector (Medical Director) is the lead researcher. A further £158,493 (2024: £1,035,248) has been approved for payment to projects led by Professor Spector.” — page 26
Per its FY2025 accounts as filed with the Charity Commission.

Accounts audited by Bourner Bullock.

Corporate structure

Public fundraising profile: JustGiving — CDRF (matched by registered charity number).

Structured financials (annual return, FY ending 05/04/2024)

Total income
£4.4m
Total spending
£1.4m
Cost of raising funds
£6k
Reserves (reported)
£633k
Employees
1

Reported reserves equal ~5.5 months of spending — below the median for charities its size (median 7.0 months; benchmarks).

Register events

Trustees

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout London

Income and spending

Financial year endIncomeSpending
05/04/2025£214k£947k
05/04/2024£4.4m£1.4m
05/04/2023£791k£1.4m
05/04/2022£481k£1.8m
05/04/2021£3.2m£690k

Common questions

Is THE CHRONIC DISEASE RESEARCH FOUNDATION financially healthy?

The accounts state that the charity reported a deficit of £732,638 for the year ended 5 April 2025, resulting in closing net assets of £5,112,615. The trustees' report confirms that unrestricted funds of £543,110 remain well above the stated policy minimum of approximately six months' projected management and administrative expenditure. The independent auditors confirmed that the use of the going concern basis of accounting is appropriate with no material uncertainties identified. Its FY2025 accounts were audited by Bourner Bullock.

Who funds THE CHRONIC DISEASE RESEARCH FOUNDATION?

Funders whose own accounts filings name THE CHRONIC DISEASE RESEARCH FOUNDATION as a grant recipient include DENISE COATES FOUNDATION.

Known funders

Grants to this charity found in funders’ own accounts filings.

FunderYearAmount
DENISE COATES FOUNDATIONFY2024£4.2m
DENISE COATES FOUNDATIONFY2023£758k

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

FunderSimilar charities fundedAmount to them
ROBERT LUFF FOUNDATION LIMITED2£60k
CECIL PILKINGTON CHARITABLE TRUST2£16k
SUSANNA PEAKE CHARITABLE TRUST2£11k
PILKINGTON CHARITIES FUND2£11k
THE OAKDALE TRUST2£4k
PROJECT GIVING BACK1£84k
JUVENILE DIABETES RESEARCH FOUNDATION LIMITED1£38k
THE THOMAS J HORNE MEMORIAL TRUST1£25k

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with PAIN RELIEF FOUNDATION.